Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer
Tanguy Y. Seiwert*, James M. Melotek, Elizabeth A. Blair, Kerstin M. Stenson, Joseph K. Salama, Mary Ellyn Witt, Ryan J. Brisson, Apoorva Chawla, Allison Dekker, Mark W. Lingen, Masha Kocherginsky, Victoria M. Villaflor, Ezra E W Cohen, Daniel J. Haraf, Everett E. Vokes
Dive into the research topics of 'Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer'. Together they form a unique fingerprint.